Literature DB >> 12032015

Acetylcholine receptors do not mediate the immobilization produced by inhaled anesthetics.

Edmond I Eger1, Yi Zhang, Michael Laster, Pamela Flood, Joan J Kendig, James M Sonner.   

Abstract

UNLABELLED: Acetylcholine receptors transmit excitatory impulses, are broadly distributed throughout the central nervous system, and are particularly sensitive to the depressant effects of inhaled anesthetics. Thus these receptors are potential mediators of the immobility produced by inhaled anesthetics. We tested this potential in rats by giving intraperitoneal atropine, scopolamine, and mecamylamine to block muscarinic (atropine and scopolamine) and neuronal nicotinic (mecamylamine) acetylcholine receptors. Block with scopolamine (up to 100 mg/kg), atropine (10 mg/kg), mecamylamine (up to 4 mg/kg), or atropine (10 mg/kg) plus mecamylamine (up to 4 mg/kg) did not significantly decrease the isoflurane concentration required to suppress movement to noxious stimulation (minimum alveolar anesthetic concentration). We also gave atropine intrathecally, finding that the infusions that did not cause permanent paralysis produced slight or no decreases in the minimum alveolar anesthetic concentration. We conclude that acetylcholine receptors do not seem to play a role as mediators of immobilization by inhaled anesthetics. IMPLICATIONS: Inhaled anesthetics produce two crucial effects: amnesia and immobility in the face of noxious stimulation. Block of muscarinic and neuronal nicotinic acetylcholine receptors in rats does not significantly decrease the isoflurane concentration required to suppress movement to stimulation. Thus, acetylcholine receptors do not seem to play a major role as mediators of the immobilization produced by inhaled anesthetics. Their capacity to mediate other effects of inhaled anesthetics (e.g., amnesia) remains to be tested.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032015     DOI: 10.1097/00000539-200206000-00023

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

Review 1.  Anaesthetic mechanisms: update on the challenge of unravelling the mystery of anaesthesia.

Authors:  Andrea Kopp Lugli; Charles Spencer Yost; Christoph H Kindler
Journal:  Eur J Anaesthesiol       Date:  2009-10       Impact factor: 4.330

2.  Hippocampal M1 receptor function associated with spatial learning and memory in aged female rhesus macaques.

Authors:  Gwendolen E Haley; Chris Kroenke; Daniel Schwartz; Steven G Kohama; Henryk F Urbanski; Jacob Raber
Journal:  Age (Dordr)       Date:  2010-10-02

3.  Carboetomidate inhibits alpha4/beta2 neuronal nicotinic acetylcholine receptors at concentrations affecting animals.

Authors:  David W Pierce; Ervin Pejo; Douglas E Raines; Stuart A Forman
Journal:  Anesth Analg       Date:  2012-04-27       Impact factor: 5.108

Review 4.  The recent progress in research on effects of anesthetics and analgesics on G protein-coupled receptors.

Authors:  Kouichiro Minami; Yasuhito Uezono
Journal:  J Anesth       Date:  2012-10-26       Impact factor: 2.078

5.  Nitrous oxide (N(2)O) requires the N-methyl-D-aspartate receptor for its action in Caenorhabditis elegans.

Authors:  P Nagele; L B Metz; C M Crowder
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-24       Impact factor: 11.205

Review 6.  Is a new paradigm needed to explain how inhaled anesthetics produce immobility?

Authors:  Edmond I Eger; Douglas E Raines; Steven L Shafer; Hugh C Hemmings; James M Sonner
Journal:  Anesth Analg       Date:  2008-09       Impact factor: 5.108

7.  Inhibition of human alpha4beta2 neuronal nicotinic acetylcholine receptors by volatile aromatic anesthetics depends on drug hydrophobicity.

Authors:  Ken Solt; Elizabeth W Kelly; Joseph F Cotten; Douglas E Raines
Journal:  Anesth Analg       Date:  2009-11-16       Impact factor: 5.108

Review 8.  Effects of General Anesthetics on Synaptic Transmission and Plasticity.

Authors:  Jimcy Platholi; Hugh C Hemmings
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.